1. Home
  2. NRXP vs ECF Comparison

NRXP vs ECF Comparison

Compare NRXP & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

N/A

Current Price

$2.45

Market Cap

151.1M

Sector

Health Care

ML Signal

N/A

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

N/A

Current Price

$11.45

Market Cap

162.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NRXP
ECF
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
162.7M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
NRXP
ECF
Price
$2.45
$11.45
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $38.75
N/A
AVG Volume (30 Days)
★ 1.3M
27.7K
Earning Date
11-24-2026
01-01-0001
Dividend Yield
N/A
★ 6.42%
EPS Growth
★ 69.70
N/A
EPS
N/A
★ N/A
Revenue
★ $1,225,000.00
N/A
Revenue This Year
$357.94
N/A
Revenue Next Year
$1,281.36
N/A
P/E Ratio
★ N/A
$25.46
Revenue Growth
N/A
N/A
52 Week Low
$1.65
$10.71
52 Week High
$5.06
$13.85

Technical Indicators

Market Signals
Indicator
NRXP
ECF
Relative Strength Index (RSI) 46.02 48.26
Support Level $1.68 $11.25
Resistance Level $2.49 $11.67
Average True Range (ATR) 0.22 0.19
MACD 0.02 0.01
Stochastic Oscillator 50.00 61.58

Price Performance

Historical Comparison
NRXP
ECF

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

Share on Social Networks: